Literature DB >> 25337265

Human leukocyte antigen-DRB1*1501 and DQB1*0602 alleles are cervical cancer protective factors among Uighur and Han people in Xinjiang, China.

Jian Ming Hu1, Qi Sun2, Ling Li3, Chun Xia Liu2, Yun Zhao Chen2, Hong Zou2, Li Juan Pang2, Jin Zhao2, Lan Yang2, Yu Wen Cao2, Xiao Bin Cui2, Yan Qi2, Wei Hua Liang2, Wen Jie Zhang2, Feng Li1.   

Abstract

Human papillomavirus (HPV) infection is a major risk factor for cervical cancer. However, only some high risk human papillomavirus (HR-HPV)-infected women progress to cervical cancer, host immunogenetic factors human leukocyte antigen (HLA) may account for viral antigens presenting individually or together in the progression to cervical cancer. This study examined the association between the development of invasive cervical cancer (ICC) and the determinant factors including HLA-DRB1*1501 and DQB1*0602, HR-HPV infection among Chinese Uighur and Han populations. Blood samples, cervical swabs and biopsies were obtained from 287 patients with ICC (192 Uighurs and 95 Hans) and 312 healthy controls (218 Uighurs and 94 Hans). HPV DNA was detected by PCR and HLA-DRB1*1501 and DQB1*0602 alleles were performed using PCR-SSP method. HPV16 infection rates was significantly higher among Uighur and Han with ICC as compared to healthy controls (OR = 58.317; 95% CI: 39.663-85.744; OR = 33.778; 95% CI: 12.581-90.691; P < 0.05 for all). HLA-DRB1*1501 (OR = 0.305; 95% CI: 0.115-0.813; P < 0.05) and HLA-DRB1*1501-DQB1*0602 haplotype frequencies (OR = 0.274; 95% CI: 0.086-0.874; P < 0.05) were significantly reduced in Han ICC. The HLA-DQB1*0602 frequency significantly decreased among Uighur women with ICC (OR = 0.482; 95% CI: 0.325-0.716; P < 0.05). Similar tendencies were observed for DQB1*0602 with HPV16-positive ICC (OR = 0.550; 95% CI: 0.362-0.837; P < 0.05). This study suggests that HLA-DRB1*1501 and DQB1*0602 alleles may influence the immune response to HPV16 infection and decrease the risk of ICC among Uighurs and Hans in Xinjiang, China.

Entities:  

Keywords:  HLA; HPV; Uighur; invasive cervical cancer; susceptibility

Mesh:

Substances:

Year:  2014        PMID: 25337265      PMCID: PMC4203236     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  29 in total

1.  Human papillomavirus is a necessary cause of invasive cervical cancer worldwide.

Authors:  J M Walboomers; M V Jacobs; M M Manos; F X Bosch; J A Kummer; K V Shah; P J Snijders; J Peto; C J Meijer; N Muñoz
Journal:  J Pathol       Date:  1999-09       Impact factor: 7.996

2.  HLA-DQB1 polymorphisms and risk for cervical cancer: a case-control study in a southern Chinese population.

Authors:  Paul K S Chan; Jo L K Cheung; Tak-Hong Cheung; C K Lin; Shing-Shun N Siu; May M Y Yu; Julian W Tang; Keith W K Lo; So-Fan Yim; Y F Wong; Ka-Fai To; H K Ng; Tony K H Chung
Journal:  Gynecol Oncol       Date:  2007-03-26       Impact factor: 5.482

3.  Global cancer statistics, 2002.

Authors:  D Max Parkin; Freddie Bray; J Ferlay; Paola Pisani
Journal:  CA Cancer J Clin       Date:  2005 Mar-Apr       Impact factor: 508.702

4.  Polymorphic amino acids at codons 9 and 37 of HLA-DQB1 alleles may confer susceptibility to cervical cancer among Chinese women.

Authors:  Yuping Wu; Yulong Chen; Longyu Li; Yicheng Cao; Zehuan Liu; Benrong Liu; Zhengping Du; Yanling Zhang; Shangwu Chen; Zhongqiu Lin; Anlong Xu
Journal:  Int J Cancer       Date:  2006-06-15       Impact factor: 7.396

5.  [Relationship between p53 Arg72Pro polymorphism and cervical carcinoma in Uigur and Han women in Xinjiang].

Authors:  Xing-zheng Zheng; An-qiang Yang; Xiao-lin Pan; Li-li Zheng; Qiu-yuan Zhou; Xin-min Li; Xiao-ling Wang; Li-hua Yan; Hong-an Li
Journal:  Zhonghua Bing Li Xue Za Zhi       Date:  2007-08

6.  Comprehensive analysis of HLA-A, HLA-B, HLA-C, HLA-DRB1, and HLA-DQB1 loci and squamous cell cervical cancer risk.

Authors:  Margaret M Madeleine; Lisa G Johnson; Anajane G Smith; John A Hansen; Brenda B Nisperos; Sue Li; Lue-Ping Zhao; Janet R Daling; Stephen M Schwartz; Denise A Galloway
Journal:  Cancer Res       Date:  2008-05-01       Impact factor: 12.701

7.  HLA-class II alleles in Egyptian patients with hepatocellular carcinoma.

Authors:  Farha A El-Chennawi; Fatma A Auf; Shereen S Metwally; Youssef M Mosaad; Mohamed A El-Wahab; Ziyad E Tawhid
Journal:  Immunol Invest       Date:  2008       Impact factor: 3.657

8.  HLA polymorphisms and cervical human Papillomavirus infection in a cohort of Montreal University students.

Authors:  Salaheddin M Mahmud; Keira Robinson; Harriet Richardson; Pierre-Paul Tellier; Alex S Ferenczy; Michel Roger; Francois Coutlee; Eduardo L Franco
Journal:  J Infect Dis       Date:  2007-05-29       Impact factor: 5.226

9.  Human leukocyte antigen class II alleles and risk of cervical cancer in China.

Authors:  Yuping Wu; Benrong Liu; Wenzhi Lin; Yunping Xu; Longyu Li; Yanling Zhang; Shangwu Chen; Zhongqiu Lin; Anlong Xu
Journal:  Hum Immunol       Date:  2006-08-07       Impact factor: 2.850

10.  Interaction between polymorphisms of the human leukocyte antigen and HPV-16 variants on the risk of invasive cervical cancer.

Authors:  Patricia S de Araujo Souza; Paulo C Maciag; Karina B Ribeiro; Maria Luiza Petzl-Erler; Eduardo L Franco; Luisa L Villa
Journal:  BMC Cancer       Date:  2008-08-22       Impact factor: 4.430

View more
  3 in total

1.  Hypermethylation of TFPI2 correlates with cervical cancer incidence in the Uygur and Han populations of Xinjiang, China.

Authors:  Yuling Dong; Qiufen Tan; Lin Tao; Xiaolin Pan; Lijuan Pang; Weihua Liang; Wei Liu; Wenjie Zhang; Feng Li; Wei Jia
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

2.  Association of HLA-DRB1, HLA-DQB1 Polymorphisms with HPV 16 E6 Variants among Young Cervical Cancer Patients in China.

Authors:  Yan Hu; Jin-Ze Wu; Hua Zhu; Sheng-Hui Zhang; Yan-Ying Zhu; Yi-Yao Wu; Ci-Xia Shuai
Journal:  J Cancer       Date:  2017-07-22       Impact factor: 4.207

Review 3.  The interplay between the vaginal microbiome and innate immunity in the focus of predictive, preventive, and personalized medical approach to combat HPV-induced cervical cancer.

Authors:  Erik Kudela; Alena Liskova; Marek Samec; Lenka Koklesova; Veronika Holubekova; Tomas Rokos; Erik Kozubik; Terezia Pribulova; Kevin Zhai; Dietrich Busselberg; Peter Kubatka; Kamil Biringer
Journal:  EPMA J       Date:  2021-05-18       Impact factor: 8.836

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.